• GPR30 in Spinal CCK+ Neurons and Neuropathic Pain

  2026-09-03

  This reference study identifies GPR30 in spinal cholecystokinin-positive neurons as a cell-type-specific regulator of nerve-injury-induced pain. By combining molecular mapping, synaptic analysis, pathway manipulation, and chemogenetics, it connects spinal GPR30 signaling with AMPA-mediated sensitization and a primary somatosensory cortex-to-dorsal horn circuit.

• Trypsin BA5744 for Reliable Cell Assays

  2026-09-02

  Learn how Trypsin (SKU BA5744) can reduce workflow variability in cell viability, proliferation, differentiation, wound healing, and proteolysis studies. This scenario-based guide separates product-supported specifications from assay recommendations and highlights practical controls for reproducible interpretation.

• GW4064 for FXR Activation in Metabolic Research

  2026-09-02

  GW4064 is a selective, non-steroidal FXR agonist for connecting receptor activation with lipid metabolism, TLR4 signaling, ferroptosis, and fibrotic phenotypes. This workflow-focused guide shows how to prepare, dose, validate, and troubleshoot GW4064 in LX-2 and broader metabolic research models.

• Estradiol, GPR30, and Immune Recovery After Shock

  2026-09-01

  The reference study shows that estradiol restores splenic CD4+ T-lymphocyte proliferation and cytokine production after hemorrhagic shock by limiting endoplasmic reticulum stress through ERα and GPR30, rather than ERβ. Its pharmacological combination of receptor-selective ligands, antagonists, and an ER-stress inducer provides a useful framework for separating classical and rapid estrogen signaling in immune-trauma research.

• G-1: Selective GPR30 Agonist Workflows

  2026-09-01

  G-1 enables rapid, receptor-focused experiments spanning calcium signaling, immune dysfunction, cancer-cell migration, and cardiovascular remodeling. This workflow-led guide shows how to separate GPR30 biology from classical estrogen-receptor effects while improving dosing, controls, and assay reproducibility.

• EdU Imaging Kits (Cy5) for Cardiac Ablation Studies

  2026-08-31

  EdU Imaging Kits (Cy5) add a direct DNA-synthesis endpoint to cardiomyocyte injury models, helping distinguish reduced metabolic activity from cell-cycle arrest or cell loss after pulsed electric fields. The morphology-preserving click-chemistry workflow supports both spatial fluorescence imaging and quantitative flow cytometry.

• Gamithromycin: Mechanism, PK/PD, and Uses

  2026-08-31

  Gamithromycin, also known as ML-1709460, is a 15-membered azalide macrolide that inhibits bacterial protein synthesis at the 50S ribosomal subunit. Cattle tissue-cage data identify AUC0–24h/MIC as the principal pharmacodynamic index for Pasteurella multocida infection, while product information emphasizes lung exposure and veterinary respiratory applications.

• EdU Imaging Kits (Cy5) for PASMC Studies

  2026-08-30

  EdU Imaging Kits (Cy5) provide a morphology-preserving way to quantify S-phase entry in pulmonary artery smooth muscle cells. This guide shows how to use EdU data to interrogate the hypoxia–PUM2–KCNK3 mechanism in pulmonary hypertension without confusing proliferation with migration or apoptosis.

• Intestinal Stretch, Weight Loss, and Glucose Control

  2026-08-29

  The reference study shows that intestinal stretch is an active satiety and glucose-regulatory signal that is weakened by diet-induced obesity but restored after dietary or surgical weight loss. Its mechanistic analyses further indicate that these effects can occur independently of classical GLP-1 signaling, expanding current models of gut–brain metabolic control.

• Hypoxia and Immunometabolism in the Tumor Microenvironment

  2026-08-28

  This 2025 review unifies tumor hypoxia, metabolic reprogramming, and immune-cell dysfunction as mutually reinforcing processes that shape an immunosuppressive tumor microenvironment. Its main practical implication is that glucose availability, oxygen gradients, HIF signaling, and immune phenotypes should be analyzed together rather than as isolated variables.

• EdU Imaging Kits (Cy5) for HB Proliferation

  2026-08-28

  EdU Imaging Kits (Cy5) convert S-phase DNA synthesis into a quantitative Cy5 signal for microscopy and flow cytometry. This article translates findings from a hepatoblastoma redox study into practical assay design, controls, optimization, and troubleshooting strategies.

• Nelfinavir Mesylate: HIV-1 Protease Workflows

  2026-08-27

  Nelfinavir Mesylate supports benchmark antiviral experiments and provides a chemically tractable way to investigate DDI2–NFE2L1 control of ferroptosis. This guide connects HIV-1 protease inhibition assays with practical cell-based workflows, solvent handling, pathway readouts, and troubleshooting strategies.

• WST-8 Glucose Uptake Assay Kit for NAFLD

  2026-08-27

  Discover how the WST-8 Glucose Uptake Assay Kit can translate Galectin-1–autophagy biology into a quantitative glucose uptake assay for NAFLD and insulin-resistance research. This guide emphasizes mechanistic interpretation, controls, and experimental decision-making rather than routine protocol optimization.

• Cepharanthine Inhibits Endometriosis Growth

  2026-08-26

  A 2026 study evaluated the biscoclaurine alkaloid Cepharanthine across endometriotic stromal cells, patient-derived endometrial organoids, and a murine peritoneal model. Its central finding is a concordant reduction in lesion growth associated with DNA damage, impaired repair, G0/G1 arrest, and mitochondria-linked apoptosis, providing a preclinical rationale for further endometriosis research.

• CNQX Workflow for AMPA/Kainate Pathway Studies

  2026-08-26

  CNQX provides a practical way to separate AMPA/kainate-driven excitation from NMDA receptor activity in neuronal and neurocardiovascular experiments. This guide translates its pharmacology into formulation, pathway-mapping, regional microinjection, and troubleshooting workflows.

8045 records 6/537 page Previous Next First page 上5页 678910 下5页 Last page